April 07, 2026 07:38 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
IRGC Intelligence Chief Majid Khademi killed in Israeli-US strike | Setback for Arunachal CM Pema Khandu as SC orders CBI probe into public works contracts | ‘Not denied a ticket’: Annamalai explains absence from BJP’s Tamil Nadu candidate list | ‘Ghar-wapsi soon’: PoK wants to return to India, claims Imam organisation chief | Kerala polls shocker: Tharoor’s convoy stopped, security guard attacked mid-campaign | AAP drops Raghav Chadha from key parliamentary role, sparks buzz over internal rift | Amit Shah to camp in West Bengal for 15 days during Assembly polls; predicts Mamata’s defeat in state and Bhabanipur | 'BJP plotting President’s Rule, don’t fall in the trap': Mamata Banerjee on Malda unrest, urges peace | 'Most polarised state': CJI Kant raps Bengal govt over 9-hour hostage of judicial officers | Bengal SIR protest: Judge pleads for help amid mob attack after 9-hour hostage ordeal
AstraZeneca
Unspalsh

Canada advisory committee recommends pausing AstraZeneca vaccine shots: Statement

| @indiablooms | Mar 30, 2021, at 02:48 pm

Toronto/Sputnik: Canada’s National Advisory Committee on Immunizations (NACI) is recommending a pause in inoculating Canadians under the age of 55 with the Oxford-AstraZeneca coronavirus vaccine citing safety concerns.

“NACI recommends that AstraZeneca COVID-19 vaccine should not be used in adults under 55 years of age at this time while the safety signal of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following vaccination with AstraZeneca COVID-19 vaccine is investigated further,” NACI said in a statement on Monday.

The updated guidance comes as European researchers have purported that an autoimmune response to AstraZeneca’s vaccine is behind the blood clots that have forced the suspension of inoculation with the vaccine in several European Union countries.

Despite the advisory committee’s warning, Canadian federal health regulators indicated to reporters that they don’t plan on changing the current federal guidance that says the AstraZeneca vaccine is safe and effective for adults over the age of 18.

“There hasn’t been enough data to show that we should make a change to the way that the vaccine is used or changes to the labeling,” Health Canada Chief Medical Advisor Supriya Sharma.

Deputy Chief Public Health Officer Dr. Howard Njoo said that those who have been vaccinated with the AstraZeneca vaccine should seek immediate medical attention if they develop symptoms including, chest pain, leg swelling and shortness of breath, between four and 16 days after being inoculated. Njoo said those who have been vaccinated more than 20 days ago have no cause for concern.

Shadow Minister of Health, Michelle Rempel Garner, during a press briefing called for greater transparency from Prime Minister Justin Trudeau and to explicitly say if Health Canada will accept the advisory committee’s recommendation.

However, a number of provinces, including Alberta, Manitoba and Newfoundland and Labrador, have announced that they are temporarily halting vaccination with the AstraZeneca shots effective immediately.

In its statement, NACI said a decision on the second vaccine dose for those already vaccinated with the AstraZeneca shot should be made based on the “latest evidence and research.”

Canadian health regulators last week issued a disclaimer regarding blood clots that may potentially form in individuals who vaccinate with the AstraZeneca coronavirus vaccine.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.